Crohn's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Crohn's Disease, including details on symptoms, diagnosis, treatment, causes, medication.

Volume 2 (2005), Issue 4 (April)

1. 6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.
   Aliment Pharmacol Ther, 21(7): 829-39. [Abstract] [Full-text]
2. Reduced expression of collagen type I and increased expression of matrix metalloproteinases 1 in patients with Crohn's disease.
   J Invest Surg, 18(1): 33-8. [Abstract] [Full-text]
3. CARD15 polymorphisms are associated with anti-Saccharomyces cerevisiae antibodies in caucasian Crohn's disease patients.
   Clin Exp Immunol, 140(2): 354-9. [Abstract] [Full-text]
4. Mycobacterium avium subsp. paratuberculosis in the catchment area and water of the River Taff in South Wales, United Kingdom, and its potential relationship to clustering of Crohn's disease cases in the city of Cardiff.
   Appl Environ Microbiol, 71(4): 2130-9. [Abstract] [Full-text]
5. Long-term treatment of high intestinal output syndrome with budesonide in patients with Crohn's disease and ileostomy.
   Dis Colon Rectum, 48(2): 237-42. [Abstract] [Full-text]
6. Pregnancy and Crohn's disease.
   Digestion, 71(1): 54-61. [Abstract] [Full-text]
7. Treatment of postoperative Crohn's disease.
   Digestion, 71(1): 49-53. [Abstract] [Full-text]
8. Maintenance of remission in Crohn's disease.
   Digestion, 71(1): 41-8. [Abstract] [Full-text]
9. Treatment of gastroduodenal Crohn's disease.
   Digestion, 71(1): 37-40. [Abstract] [Full-text]
10. Extraintestinal manifestations of Crohn's disease.
    Digestion, 71(1): 31-6. [Abstract] [Full-text]
11. Obstructive fibrostenotic Crohn's disease.
    Digestion, 71(1): 29-30. [Abstract] [Full-text]
12. Fistulizing Crohn's disease.
    Digestion, 71(1): 26-8. [Abstract] [Full-text]
13. Severe and steroid-resistant Crohn's disease.
    Digestion, 71(1): 19-25. [Abstract] [Full-text]
14. Therapy of mild to moderate luminal Crohn's disease.
    Digestion, 71(1): 13-8. [Abstract] [Full-text]
15. Drug safety in the treatment of Crohn's disease.
    Digestion, 71(1): 8-12. [Abstract] [Full-text]
16. Review article: smoking cessation as primary therapy to modify the course of Crohn's disease.
    Aliment Pharmacol Ther, 21(8): 921-31. [Abstract] [Full-text]
17. Inhibition of RICK/nuclear factor-kappaB and p38 signaling attenuates the inflammatory response in a murine model of Crohn disease.
    J Biol Chem, 280(15): 14981-8. [Abstract] [Full-text]
18. Patient education in inflammatory bowel disease does not influence patients knowledge and long-term psychosocial well-being.
    Z Gastroenterol, 43(4): 367-71. [Abstract] [Full-text]
19. A functional interleukin-10 mutation in Dutch patients with Crohn's disease.
    Dig Liver Dis, 37(5): 330-5. [Abstract] [Full-text]
20. Tumor necrosis factor receptor gene polymorphisms in Crohn's disease: association with clinical phenotypes.
    Am J Gastroenterol, 100(5): 1126-33. [Abstract] [Full-text]
21. Increased rates of early adverse reaction to azathioprine in patients with Crohn's disease compared to autoimmune hepatitis: a tertiary referral center experience.
    Am J Gastroenterol, 100(5): 1121-5. [Abstract] [Full-text]
22. Comparison between prospective and retrospective evaluation of Crohn's disease activity index.
    Am J Gastroenterol, 100(5): 1117-20. [Abstract] [Full-text]
23. Cyclosporine for induction of remission in Crohn's disease.
    Cochrane Database Syst Rev. [Abstract] [Full-text]
24. Metastatic Crohn's disease mimicking genital pyoderma gangrenosum in an HIV patient.
    Acta Derm Venereol, 85(1): 60-2. [Abstract] [Full-text]
25. Diverse effects of infliximab and etanercept on T lymphocytes.
    Semin Arthritis Rheum, 34(5): 23-7. [Abstract] [Full-text]
26. Management of inflammatory bowel disease: does rifaximin offer any promise?
    Chemotherapy, 51: 96-102. [Abstract] [Full-text]
27. Seasonality of vitamin D status and bone turnover in patients with Crohn's disease.
    Aliment Pharmacol Ther, 21(9): 1073-83. [Abstract] [Full-text]
28. Infliximab reverses growth hormone resistance associated with inflammatory bowel disease.
    Aliment Pharmacol Ther, 21(9): 1063-71. [Abstract] [Full-text]
29. Segmental colonoscopic biopsies in the differentiation of ileocolic tuberculosis from Crohn's disease.
    J Gastroenterol Hepatol, 20(5): 688-96. [Abstract] [Full-text]
30. Genetics of Crohn disease, an archetypal inflammatory barrier disease.
    Nat Rev Genet, 6(5): 376-88. [Abstract] [Full-text]
31. Long-term outcomes of restorative proctocolectomy for Crohn's disease and indeterminate colitis.
    Colorectal Dis, 7(3): 218-23. [Abstract] [Full-text]

© 2004-2008 Crohn's Disease Research Today. All Rights Reserved.